Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 7/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | MAPT | P10636 | 2/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | HTT | P42858 | 1/20 | 0.50 |
| ▸ | ESR1 | P03372 | 1/20 | 0.44 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 2/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.39 |
| ▸ | EGFR | P00533 | 1/20 | 0.38 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.38 |
| ▸ | SLC22A2 | O15244 | 1/20 | 0.36 |
| ▸ | TMPRSS2 | O15393 | 1/20 | 0.36 |
| ▸ | F2 | P00734 | 1/20 | 0.36 |
| ▸ | F10 | P00742 | 1/20 | 0.36 |
| ▸ | PLG | P00747 | 1/20 | 0.36 |
| ▸ | F12 | P00748 | 1/20 | 0.36 |
| ▸ | PLAU | P00749 | 1/20 | 0.36 |
| ▸ | PLAT | P00750 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19470771 | 0.93 | KMT2A (0.51) | KMT2AHSD17B10ALDH1A1MAPTLMNA | |
| SCHEMBL28886327 | 0.81 | L3MBTL1 (0.46) | KMT2AMAPTHTTMEN1SMN1; SMN2 | |
| SCHEMBL1969461 | 0.79 | LMNA (0.48) | KMT2AHSD17B10ALDH1A1MAPTLMNA | |
| SCHEMBL19086434 | 0.77 | ELANE (0.42) | KMT2AHSD17B10ALDH1A1MAPTLMNA | |
| SCHEMBL5556095 | 0.77 | SMN1; SMN2 (0.50) | KMT2AMAPTMEN1SMN1; SMN2FAAH | |
| SCHEMBL378101 | 0.76 | KMT2A (0.49) | KMT2AALDH1A1HTTMEN1SMN1; SMN2 | |
| SCHEMBL5551276 | 0.75 | LTA4H (0.48) | KMT2AMAPTMEN1SMN1; SMN2 | |
| SCHEMBL19086385 | 0.75 | KMT2A (0.59) | KMT2AHSD17B10ALDH1A1MAPTLMNA | |
| SCHEMBL9000712 | 0.75 | SMN1; SMN2 (0.57) | LMNAHIF1ASMN1; SMN2CYP1A2CYP2D6 | |
| SCHEMBL20484981 | 0.74 | ACACB (0.50) | KMT2AALDH1A1LMNAMEN1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3190131-B1 | LIVING RADICAL POLYMERIZATION INITIATOR, METHOD FOR PRODUCING POLYMER, AND POLYMER | UNIV KYOTO (JP) | 2020-07-29 | — | — | EP | disclosed |
| US-10414848-B2 | Living radical polymerization initiator, method for producing polymer, and polymer | KYOTO UNIVERSITY (JP) | 2019-09-17 | — | — | US | disclosed |
| US-20170306073-A1 | LIVING RADICAL POLYMERIZATION INITIATOR, METHOD FOR PRODUCING POLYMER, AND POLYMER | KYOTO UNIVERSITY (JP) | 2017-10-26 | — | — | US | disclosed |
| EP-3190131-A1 | LIVING RADICAL POLYMERIZATION INITIATOR, METHOD FOR PRODUCING POLYMER, AND POLYMER | Kyoto University (JP) | 2017-07-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10414848-B2 | Living radical polymerization initiator, method for producing polymer, and polymer | CCNY, MTR, PARN | KMT2A 453/4885HSD17B10 3157/4885ALDH1A1 2596/4885 |
| US-20170306073-A1 | LIVING RADICAL POLYMERIZATION INITIATOR, METHOD FOR PRODUCING POLYMER, AND POLYMER | CCNY, MTR, PARN | KMT2A 453/4885HSD17B10 3157/4885ALDH1A1 2596/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.